Premium
Divergent binding sites on intercellular adhesion molecule‐1 (ICAM‐1) for variant Plasmodium falciparum isolates
Author(s) -
Tse Man Tsuey,
Chakrabarti Kausik,
Gray Carolyn,
Chitnis Chetan E.,
Craig Alister
Publication year - 2004
Publication title -
molecular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 247
eISSN - 1365-2958
pISSN - 0950-382X
DOI - 10.1046/j.1365-2958.2003.03895.x
Subject(s) - biology , plasmodium falciparum , intercellular adhesion molecule 1 , phenotype , avidity , cerebral malaria , icam 1 , endothelium , plasmodium (life cycle) , intracellular , microbiology and biotechnology , parasite hosting , malaria , immunology , genetics , gene , antibody , world wide web , computer science
Summary Adhesion of human erythrocytes infected with the malaria parasite Plasmodium falciparum to host endothelium has been associated with severe forms of this disease. A number of endothelial receptors have been identified, and there is evidence that one of these, intercellular adhesion molecule‐1 (ICAM‐1), may play an important role in the pathology of cerebral malaria. Mutagenesis of domain 1 of ICAM‐1, which is involved in parasite adhesion, shows that the binding sites for different parasite variants overlap to a large extent, but that there are subtle differences between them that correlate with their adhesive phenotypes. This suggests that the ability to bind to ICAM‐1 has arisen from a common variant, but that subsequent changes have led to differences in binding avidity, which may affect pathogenesis. The definition of common binding determinants and the elucidation of links between ICAM‐1 binding phenotype and disease will provide new leads in the design of therapeutic interventions.